Security key
45258H106
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 52,769,253
- Total 13F shares
- 2,765,928
- Share change
- +436,277
- Total reported value
- $5,781,309
- Price per share
- $2.09
- Number of holders
- 31
- Value change
- +$912,474
- Number of buys
- 18
- Number of sells
- 8
Report period
Q3 2025
Institutions
31
Top holders
10
IMMX full security history
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Immix Biopharma, Inc. SEC filings
Immix Biopharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45258H106
Recent filing periods:
Top shareholders of IMMX - Immix Biopharma, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Bleichroeder LP |
13F
|
Company |
1.6%
|
850,000
|
$1,759,500 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.3%
|
698,537
|
$1,445,972 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.31%
|
161,115
|
$333,550 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.24%
|
124,919
|
$258,583 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.18%
|
93,888
|
$194,348 | — | 30 Jun 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.1%
|
50,826
|
$105,210 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.08%
|
42,960
|
$88,927 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.08%
|
40,301
|
$83,423 | — | 30 Jun 2025 | |
| Private Advisor Group, LLC |
13F
|
Company |
0.06%
|
31,225
|
$64,637 | — | 30 Jun 2025 | |
| TOCQUEVILLE ASSET MANAGEMENT L.P. |
13F
|
Company |
0.06%
|
29,300
|
$60,651 | — | 30 Jun 2025 | |
| Velan Capital Investment Management LP |
13F
|
Company |
0.05%
|
25,000
|
$51,750 | — | 30 Jun 2025 | |
| TRITONPOINT WEALTH, LLC |
13F
|
Company |
0.05%
|
24,526
|
$50,769 | — | 30 Jun 2025 | |
| Virtu Financial LLC |
13F
|
Company |
0.03%
|
17,846
|
$37,000 | — | 30 Jun 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0.03%
|
17,500
|
$36,225 | — | 30 Jun 2025 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.03%
|
16,040
|
$33,000 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.03%
|
13,972
|
$28,922 | — | 30 Jun 2025 | |
| Focus Partners Wealth |
13F
|
Company |
0.02%
|
11,900
|
$24,633 | — | 30 Jun 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.02%
|
11,168
|
$23,000 | — | 30 Jun 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0%
|
525
|
$1,087 | — | 30 Jun 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
330
|
$683 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
139
|
$288 | — | 30 Jun 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
131
|
$271 | — | 30 Jun 2025 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0%
|
80
|
$166 | — | 30 Jun 2025 | |
| Yekaterina Chudnovsky |
3/4/5
|
Director, 10%+ Owner |
—
mixed-class rows
|
3,274,076
mixed-class rows
|
$6,449,741 | — | 20 Jun 2025 | |
| Sean Senn |
3/4/5
|
Under 10% owner |
—
class O/S missing
|
899,800
|
$4,205,665 | — | 14 Jul 2022 | |
| Vladimir P. Torchilin |
3/4/5
|
Scientific Co-Founder |
—
class O/S missing
|
905,200
|
$4,230,905 | — | 20 Dec 2021 | |
| Carey Ng |
3/4/5
|
Director |
—
mixed-class rows
|
1,078,221
mixed-class rows
|
$2,079,989 | — | 20 Jun 2025 | |
| Jason Hsu |
3/4/5
|
Director |
—
mixed-class rows
|
976,000
mixed-class rows
|
$1,876,570 | — | 20 Jun 2025 | |
| Helen C. Adams |
3/4/5
|
Director |
—
mixed-class rows
|
207,754
mixed-class rows
|
$347,760 | — | 20 Jun 2025 | |
| Magda Marquet |
3/4/5
|
Director |
—
mixed-class rows
|
99,092
mixed-class rows
|
$131,523 | — | 20 Jun 2025 | |
| Jane Buchan |
3/4/5
|
Director |
—
mixed-class rows
|
55,455
mixed-class rows
|
$44,685 | — | 20 Jun 2025 |
Institutional Holders of Immix Biopharma, Inc. - Common Stock (IMMX) as of Q3 2025
As of 30 Sep 2025,
Immix Biopharma, Inc. - Common Stock (IMMX) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,765,928 shares.
The largest 10 holders included
Bleichroeder LP, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, STATE STREET CORP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, CITADEL ADVISORS LLC, NORTHERN TRUST CORP, UNITED CAPITAL FINANCIAL ADVISORS, LLC, and Imprint Wealth LLC.
This page lists
31
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
23
Q3 2025 holders
31
Holder diff
8
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.